Umifenovir receives DCGI approval for Phase III clinical trial
Council of Scientific and Industrial Research constituent lab CSIR-Central Drug Research Institute (CDRI) Lucknow has received approval for carrying out Phase III randomised, double-blind, placebo-controlled trial of efficacy, safety and tolerability of antiviral drug Umifenovir. Daily Current Affairs Quiz 2020 Key-Points The Phase III Clinical Trials will be carried out at King George’s Medical University […]
Umifenovir receives DCGI approval for Phase III clinical trial Read More »










